PaxlovidTM Information From FDA and Guidance for AES Members
Sign Up to like & getrecommendations! Published in 2022 at "Epilepsy Currents"
DOI: 10.1177/15357597221088415
Abstract: This American Epilepsy Society (AES) official statement provides information and preliminary guidance to Society members related to the U.S. Food & Drug Administration (FDA) December 22, 2021 Emergency Use Authorization for Paxlovid™ for the oral… read more here.
Keywords: information; guidance aes; paxlovidtm information; guidance ... See more keywords